Martin F Kaiser, MD¹, Andrew Hall^2*, Rachel Phillip^3*, Amy Holroyd^4*, Elsa Ferris^4*, Sadie Roberts^3*, Laura Clayton^2*, Kristian Bowles, MBBS, PhD⁵, Mamta Garg, MD^6*, Anand Lokare^7*, Ruth M de Tute, MSc, PhD, FRCPath^8*, Mark Drayson^9*, Christina Messiou^10*, Roger G Owen, MD, MRCP, FRCPath^8*, Richard S Houlston^4*, Graham Jackson, MD^11*, Gordon Cook, PhD, DSc^12,13,14*, Guy Pratt^15*, Sarah R Brown, PhD^3* and Matthew W. Jenner^16*

¹The Royal Marsden NHS Foundation Trust, London, United Kingdom
²Cancer Research UK Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
³Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁴The Institute of Cancer Research, London, United Kingdom
⁵Norwich Medical School, University of East Anglia, Norwich, United Kingdom
⁶University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
⁷Department of Haematology, Heartlands Hospital, University Hospitals Birmingham, Birmingham, United Kingdom
⁸HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁹University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom
¹⁰The Royal Marsden Hospital, Department of Radiology, London, United Kingdom
¹¹University of Newcastle, Department of Haematology, Newcastle, United Kingdom
¹²CRUK Clinical Trials Unit, Leeds Institute of Clinical Tial Research, Leeds Myeloma Research Group and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom
¹³Leeds Teaching Hospitals NHS Trust, Leeds Cancer Centre, Leeds, United Kingdom
¹⁴Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
¹⁵University Hospitals Birmingham NHS FT, Birmingham, United Kingdom
¹⁶University Hospital Southampton, Southampton, United Kingdom

Shebli Atrash, MD, MS¹, Sarah A. Holstein, MD, PhD², Hira Mian, MD³, Meletios A. Dimopoulos, MD⁴, Fredrik Schjesvold, MD, PhD⁵, Rakesh Popat, MBBS, PhD⁶, Nishi Shah, MBBS, MPH⁷, Moshe E Gatt, MD⁸, Christian B. Gocke, MD, PhD⁹, Laurent Frenzel^10*, Cyrille Touzeau, MD, PhD^11*, Meral Beksac, MD¹², Salomon Manier, MD, PhD¹³, Hila Magen^14*, Patrick M. Travis, MD^15*, Omar Nadeem, MD¹⁶, Kaveri Suryanarayan^17*, Shuli Li^17*, Xavier Parot^17* and Dan T. Vogl, MD, MS¹⁸

¹Levine Cancer Institute, Charlotte, NC
²University of Nebraska Medical Center, Omaha, NE
³McMaster University, Hamilton, ON, Canada
⁴National and Kapodistrian University of Athens, Athens, Greece
⁵Oslo University Hospital, Oslo, Norway
⁶University College London Hospital, London, United Kingdom
⁷Montefiore Medical Center, New York, NY
⁸Hadassah University Hospital, Jerusalem, Israel
⁹Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
¹⁰Necker Hospital, Paris, France
¹¹Centre Hospitalier Universitaire de Nantes, Nantes, France
¹²Hematology, Istinye University Ankara Liv Hospital, Ankara, Turkey
¹³Lille University Hospital, Lille, France
¹⁴Sheba Medical Center, Ramat Gan, Israel
¹⁵Highlands Oncology Group, P.A., Fayetteville, AR
¹⁶Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA
¹⁷Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
¹⁸Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Gang An^1*, Lijie Xing, MD^2*, Wenming Chen^3*, Yan Zhang^4*, Wen Gao⁵, Lu-Gui Qiu, M.D.¹, Guojin Wu, PhD^6*, Jinying Ning, PhD^6*, Min Wei^7* and Feng Li, PhD^7*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Department of Lymphoma and Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji Nan, China
³Department of Hematology, Beijing Chao-Yang Hospital of Capital Medical University, Beijing, China
⁴Shandong First Medical University (Shandong Academy Of Medical Sciences), Jinan, China
⁵Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
⁶KYinno Biotechnology (Beijing) Co., Ltd., Beijing, China
⁷Beijing Mabworks Biotech Co., Ltd., Beijing, China

Carolina Schinke, MD¹, Gareth Morgan, M.D., Ph.D.^2*, Luciano J. Costa, MD, PhD³, Natalie Callander, MD⁴, Don A. Stevens, MD⁵, Jesus G Berdeja, MD⁶, Brea Lipe, MD⁷, Sagar Lonial, MD^8*, Marie-Christiane Vekemans^9*, Ravi Vij, MD, MBA¹⁰, Philippe Moreau, MD, PhD^11*, Paula Rodríguez-Otero, MD, PhD^12*, Anna Sureda Balari, MD, PhD¹³, Thomas Renaud, MD¹⁴, Jaszianne Tolbert, MD¹⁵, Bonnie W Lau^15*, Brandi W Hilder, PhD¹⁵, Tara J Masterson, MS^15*, Michela Campagna, PhD^16*, Veronique Vreys^17*, Christoph Heuck, MD^15*, Colleen Kane, PhD¹⁵, Kathleen S Gray^18*, Deeksha Vishwamitra¹⁵, Indrajeet Singh^15*, Joy Gong^15*, Xiang Qin^15* and Larysa Sanchez, MD^19*

¹Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
²New York University Langone, New York, NY
³Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Vestavia, AL
⁴University of Wisconsin, Carbone Cancer Center, Madison, WI
⁵Norton Cancer Institute, Louisville, KY
⁶Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN
⁷University of Rochester Medical Center, Rochester, NY
⁸Winship Cancer Institute, Atlanta, GA
⁹Cliniques Universitaires Saint-Luc, Brussels, Belgium
¹⁰Washington University School of Medicine, Saint Louis, MO
¹¹University Hospital Hôtel-Dieu, Nantes, France
¹²Clinica Universidad de Navarra, Madrid, Spain
¹³Institut Català d'Oncologia – Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain
¹⁴Janssen Research & Development, Raritan, NJ
¹⁵Janssen Research & Development, Spring House, PA
¹⁶Janssen Research & Development, Madrid, Spain
¹⁷Janssen Research & Development, Beerse, Belgium
¹⁸Janssen Research & Development, Bridgewater, NJ
¹⁹Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY

Angely Loubert^1*, Laurine Bunod^1*, Manal M'Hari, MSc^1*, Farrah Pompilus^2*, Molly Purser, PhD^3* and Simon McNamara, PhD^4*

¹Modus Outcomes, Lyon, France
²GSK, Boston, MA
³GSK, Collegeville, PA
⁴GSK, Stevenage, Hertfordshire, United Kingdom

Vania Hungria, MD, PhD¹, Marek Hus, MD, PhD^2*, Pawel Robak, MD, PhD^3*, Vera Zherebtsova, MD^4*, Ana Carolina de Almeida Ribas, PhD, MSc^5*, Marcelo Pitombeira de Lacerda, MD, PhD^6*, Kihyun Kim, MD^7*, Sebastian Grosicki, MD, PhD^8*, Irwindeep Sandhu, MD^9*, Christopher Ward, MD, PhD^10*, Astrid McKeown, PhD^11*, Hena Baig, BS^12*, Jie Ma, PhD¹³, Benjamin Lariviere^13*, Benga Kazeem, PhD^11*, Lydia Eccersley, MBBS, MRCP, FRCPath, PhD^14*, Sumita Roy-Ghanta, MD^15*, Joanna Opalinska, MD, PhD¹⁶ and Maria Victoria Mateos, MD, PhD¹⁷

¹Clinica São Germano, São Paulo, Brazil
²Medical University of Lublin, Lublin, Poland
³Medical University of Lodz, Lodz, Poland
⁴Gorodskaya Klinicheskaya Bol’nitsa Im. S.p. Botkina, Moscow, Russian Federation
⁵Centro de Pesquisa e Ensino em Saúde de Santa Catarin, Florianópolis, Brazil
⁶Universidade da Região de Joinville (Univille), Joinville, Santa Catarina, Brazil
⁷Sungkyunkwan University, Samsung Medical Center, Seoul, Korea, Republic of (South)
⁸Medical University of Silesia, Katowice, Poland
⁹University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada
¹⁰Royal North Shore Hospital, Sydney, NSW, Australia
¹¹GSK, Stevenage, United Kingdom
¹²GSK, Mississauga, Ontario, CAN
¹³GSK, Waltham, MA
¹⁴GSK, London, United Kingdom
¹⁵GSK, Upper Providence, PA
¹⁶GSK, Philadelphia, PA
¹⁷Hospital Universitario de Salamanca/IBSAL/CIC/Ciberonc, Salamanca, Spain

Omar Nadeem, MD¹, Sophie Magidson, BS^2*, Robert A. Redd, MS^3*, Jacob P. Laubach^2*, Clifton C. Mo, MD², Elizabeth K. O'Donnell, MD², Adam S. Sperling, MD, PhD⁴, Monique A. Hartley-Brown, MD², Shonali Midha, MD^5*, Yuxin Liu, MD², Frances Arters, PA-C^6*, Marjorie Marto^2*, Christine Davie^2*, Caroline Ricciardi^2*, Dechen Choden^2*, Ashlee Strutevant^2*, Jillian Alberti^2*, Amy Goguen^2*, Michael Constantine, MD^7*, Pedro Sanz-Altamira, MD, PhD^6*, Lorenzo Trippa, PhD^3*, Nikhil C. Munshi, MD², Kenneth C. Anderson, MD², Paul G. Richardson² and Irene Ghobrial, MD²

¹Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Division of Hematology, Brigham and Women's Hospital, Boston, MA
⁵Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Dana-Farber Cancer Institute, Boston
⁷Dana-Farber Cancer Institute, Milford, MA

Evangelos Terpos, MD, PhD¹, Efstathios Kastritis, MD^1*, Sosana Delimpasi, MD^2*, Maria Kotsopoulou, MD^3*, Konstantina Papathanasiou, MD^4*, Vasiliki Labropoulou, MD^5*, Eirini Katodrytou^6*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^1*, Panagiotis Malandrakis, MD^1*, Despina Fotiou, MD^1*, Magdalini Migkou, MD^1*, Foteini Theodorakakou, MD^1*, Vasiliki Spiliopoulou, MD^1*, Nikolaos Kanellias^1*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Giorgos Psarros, MSc^7*, Maria Gavriatopoulou^1* and Meletios Dimopoulos, MD¹

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
³Department of Hematology, Metaxa Cancer Hospital, Piraeus, Greece
⁴Department of Hematology, Faculty of Medicine, University of Ioannina, Ioannina, Greece
⁵Hematology Division, Department of Internal Medicine, University of Patras, Medical School, Patras, Greece
⁶Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
⁷Health Data Specialists, Dublin, Ireland

Sridevi Rajeeve, MD¹, Andriy Derkach, PhD^2*, Sean M. Devlin, PhD^2*, Jeannen Santos^3*, Anna Przemielewska^3*, Tara Sood^4*, Kylee H Maclachlan, PhD, BSc, FRACP, FRCPA⁴, Hamza Sloan Hashmi, MD^5*, Carlyn Rose Tan, MD⁶, Neha Korde, MD⁴, Malin Hultcrantz, MD⁴, Parastoo B Dahi, MD^7*, Alexander M. Lesokhin, MD⁸, Michael Scordo, MD⁹, David J. Chung, MD, PhD¹⁰, Heather J. Landau, MD¹⁰, Gunjan L. Shah, MD⁷, Ola Landgren¹¹, Sergio A. Giralt, MD¹², Sham Mailankody, MD, MBBS⁴, Saad Z. Usmani, MD⁴ and Urvi A. Shah, MD⁴

¹Myeloma & Cellular Therapy Services/Dept of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁴Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Myeloma Service, Department of Medicine, Memorial Sloan Kettering, New York, NY
⁶Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Ardmore, PA
⁷Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Myeloma & Cell Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY
¹⁰Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Sylvester Comprehensive Cancer Center, Miami, FL
¹²Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Zachary J. Walker, BS, MS^*, Deng Wang^*, Sarah E. Parzych, BA^*, Lauren T. Reiman, BSc^*, Jacob Joram^*, Meghan Straubel^*, Alfonso Roque^*, Kaylynn Imsande^*, Katie Zhou^*, Peter A. Forsberg, MD and Daniel W. Sherbenou, MD, PhD

Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO

Binod Dhakal, MBBS¹, Hang Quach, MD, FRACP, FRCPA, MBBS², Phoebe Joy Ho, MBBS³, Andrew Spencer, MBBS, DM (Lond), FRACP, FRCPA^4*, Mark A. Schroeder, MD⁵, Peter T. Tan, MBBS⁶, Tara Cochrane, MBBS, FRCPA, FRACP⁷, Hanlon Sia, MBBS FRACP FRCPA^8*, Jeffrey A. Zonder, MD ⁹, Camille Martinet^10*, Dominique Duchesne^11*, Andrew Garton, PhD^11*, Vinu Menon^12*, Beata Holkova, MD¹³, Cyril Konto, MD¹², Lida Pacaud, MD^14* and Dickran Kazandjian, MD¹⁵

¹Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²St. Vincent's Hospital Melbourne, East Melbourne, Australia
³Royal Prince Alfred Hospital, Camperdown, NSW, Australia
⁴Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
⁵Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁶One Clinical Research, Nedlands, Australia
⁷Gold Coast University Hospital and Griffith University, Gold Coast, QLD, Australia
⁸Pindara Private Hospital, Gold Coast, Australia
⁹Karmanos Cancer Institute, Detroit, MI
¹⁰Medqualis, Montreal, Canada
¹¹Ichnos Sciences Inc., New York
¹²Ichnos Sciences, New York, NY
¹³Ichnos Sciences Inc, New York
¹⁴Ichnos Sciences Inc., New York, NY
¹⁵Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Natalie Callander, MD¹, Gayathri Ravi, MD², Rebecca W. Silbermann³, Zhubin J. Gahvari, MD, MS⁴, Eva Medvedova, MD^5*, Bhagirathbhai R. Dholaria, MBBS⁶, Naresh Bumma, MD⁷, Doris K. Hansen, MD⁸, Everette M Colquette^9*, Pamela Hardwick^9* and Luciano J. Costa, MD, PhD¹⁰

¹University of Wisconsin, Carbone Cancer Center, Madison, WI
²Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
³Oregon Health and Science University, Portland, OR
⁴Carbone Cancer Center, University of Wisconsin-Madison, Madison
⁵Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁶Vanderbilt University Medical Center, Nashville, TN
⁷The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
⁸Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁹O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
¹⁰Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Vestavia, AL

Binod Dhakal, MBBS¹, Andrew J. Yee, MD², Paul G. Richardson³, Sikander Ailawadhi⁴, Saurabh Chhabra, MD⁵, Eli Muchtar, MD⁶, Jesús G. Berdeja, MD⁷, Shambavi Richard, MD⁸, Jeffrey V Matous, MD⁹, Urvi A. Shah, MD¹⁰, Mark A. Schroeder, MD¹¹, Amro Ali, PharmD^12*, Leah Leahy, BS^12*, Riadh Lobbardi, PhD^12*, Rong Chu, PhD^12*, Eunju Hurh, PhD^12*, Anthony S. Fiorino, MD, PhD^12* and Sagar Lonial, MD^13*

¹Medical College of Wisconsin, Milwaukee, WI
²Massachusetts General Hospital Cancer Center, Boston, MA
³Dana-Farber Cancer Institute, Boston, MA
⁴Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
⁵Division of Hematology, Mayo Clinic, Phoenix, AZ
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷Tennessee Oncology, Nashville, TN
⁸Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁹Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO
¹⁰Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Division of Oncology, Washington University School of Medicine, St. Louis, MO
¹²C4 Therapeutics, Watertown, MA
¹³Winship Cancer Institute, Emory University, Atlanta, GA

Isha Mol^1*, Yannan Hu, PhD^1*, Thomas W. LeBlanc, MD, MA, MS², Joseph C. Cappelleri, PhD^3*, Haitao Chu, PhD, MD^4*, Guido Nador^5*, Didem Aydin, MD, PhD^6*, Isabel Perez-Cruz^4* and Patrick Hlavacek^4*

¹Cytel, Rotterdam, Netherlands
²Duke Cancer Institute, Hillsborough, NC
³Pfizer Inc, Groton, CT
⁴Pfizer Inc, New York, NY
⁵Pfizer Ltd, Surrey, United Kingdom
⁶Pfizer Inc, Istanbul, Turkey

Murali Janakiram, MD¹, Carlyn Rose Tan, MD², Rakesh Popat, MBBS, PhD³, Joaquín Martínez Lopez^4*, Efstathios Kastritis, MD^5*, Chris Lau^6*, Wee-Joo Chng, FRCP, FRCPath, PhD⁷, Prashant Kapoor, MD⁸, Hira Mian, MD⁹, Susan Bal, MD^10*, Ajay K. Nooka, MD, MPH¹¹, Andre De Menezes Silva Corraes, MD^12*, Magdalena Corona^13*, Arnab Chowdhury, PhD^1*, Yi Lin, MD, PhD¹², Thomas G. Martin, MD¹⁴ and Amrita Y Krishnan, MD, FACP¹⁵

¹Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
²Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Ardmore, PA
³UCL Cancer Institute, University College London, London, United Kingdom
⁴Department of Hematology, Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC, Madrid, Spain
⁵Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Voula,Athens, AL, Greece
⁶NIHR/University College London Hospital Clinical Research Facility, NHS Foundation Trust, London, United Kingdom
⁷National University Cancer Institute of Singapore, Singapore, Singapore
⁸Mayo Clinic, Rochester, MN
⁹McMaster University, Hamilton, ON, Canada
¹⁰University of Alabama at Birmingham, Birmingham, AL
¹¹Winship Cancer Institute of Emory University, Atlanta
¹²Division of Hematology, Mayo Clinic, Rochester, MN
¹³University of Complutense, Hospital 12 de Octubre, Madrid, Spain
¹⁴Department of Hematology, University of California at San Francisco, San Francisco, CA
¹⁵City of Hope Comprehensive Cancer Center, Duarte, CA

Mansi R. Shah, MD¹, Joshua Richter, MD², Hans C. Lee, MD³, Attaya Suvannasankha^4*, James E. Hoffman⁵, Suzanne Lentzsch, MD, PhD⁶, Sundar Jagannath², Jeffrey A. Zonder, MD ⁷, Rachid Baz, MD⁸, Swathi Namburi⁹, Ka Lung Wu¹⁰, Madhav V. Dhodapkar, MD PhD¹¹, Joseph J. Maly^12*, Rebecca Silbermann¹³, Chang-Ki Min^14*, Matthew Pianko¹⁵, Marie-Christiane Vekemans^16*, Markus Munder^17*, Ja Min Byun, MD, PhD¹⁸, Joaquín Martínez-Lopez^19*, Michelle DeVeaux^20*, Dhruti Chokshi^20*, Megan Seraphin^20*, Anita Boyapati^20*, Anasuya Hazra^20*, Glenn S. Kroog^20*, Kate Knorr^20* and Naresh Bumma, MD²¹

¹Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
²Icahn School of Medicine at Mount Sinai, New York, NY
³The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Indiana University Simon Cancer Center and Roudebush VAMC, Indianapolis, IN
⁵University of Miami Health System, Miami, FL
⁶Columbia University Medical Center, New York, NY
⁷Karmanos Cancer Institute, Detroit, MI
⁸Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
⁹Swedish Cancer Institute, Seattle, WA
¹⁰Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium
¹¹Emory University, Atlanta, GA
¹²Norton Cancer Institute, Louisville, KY
¹³Knight Cancer Institute, Oregon Health & Science University, Portland, OR
¹⁴Department of Hematology, Seoul St. Mary's Hospital,The Catholic University of Korea, Seoul, Korea, Republic of (South)
¹⁵Rogel Cancer Center, University of Michigan, Ann Arbor, MI
¹⁶Department of Internal Medicine, Université Catholique de Louvain (UCLouvain), Brussels, Belgium
¹⁷Third Department of Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
¹⁸Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
¹⁹Hospital Universitario 12 de octubre, Universidad Complutense, CNIO, Madrid, Spain
²⁰Regeneron Pharmaceuticals, Inc., Tarrytown, NY
²¹The Ohio State University Comprehensive Cancer Center, Columbus, OH

Pierre Bories, MD^1*, Cristina Gasparetto, MD^2*, David Dingli, MD, PhD³, Sagar Lonial, MD^4*, Saad Z. Usmani, MD⁵, Jesus G Berdeja, MD⁶, Alfred Chung, MD⁷, Aimaz Afrough, MD⁸, Laura Rosiñol, MD, PhD^9*, Andrew J. Yee, MD^10*, Suzanne Trudel, MD, MSc^11,12, David S. Siegel, MD, PhD¹³, Paula Rodríguez-Otero, MD, PhD^14*, Soo Bang, MHSA^15*, Terry Connolly, PhD^15*, Chad A. Lewis, PhD^15*, Erin Flynt, PhD^15*, Julie Vazquez, RN, MSN^15*, Sanjana U. Miskin, MSc^15*, Benjamin Winograd, MD, PhD^15*, Maria-Victoria Mateos, MD, PhD¹⁶, Cyrille Touzeau, MD, PhD^17,18* and Vivek Roy, MD¹⁹

¹Department of Hematology, Toulouse University Institute of Cancer, Toulouse, France
²Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Winship Cancer Institute, Emory University, Atlanta, GA
⁵Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Tennessee Oncology, Nashville
⁷Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA
⁸Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Coppell, TX
⁹Hematology, IDIBAPS, Hospital Clinic, Barcelona, ESP
¹⁰Massachusetts General Hospital, Boston, MA
¹¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
¹²Princess Margaret Cancer Centre, Toronto, ON, Canada
¹³Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹⁴Clínica Universidad de Navarra, Pamplona, Spain
¹⁵K36 Therapeutics, Cambridge, MA
¹⁶Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBASL), Centro de Investigación del Cáncer (IBMCC-USAL, CSIC), Salamanca, Spain
¹⁷Centre Hospitalier Universitaire de Nantes, Nantes, France
¹⁸University Hospital Nantes, Nantes, France
¹⁹Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL

Charlotte L.B.M. Korst^1,2*, Wouter Plattel, MD, PhD^3*, Elizabeth de Kort^4*, Alexandra Croockewit, MD, PhD^4*, Mark-David Levin⁵, Matthijs Westerman, MD^6*, Okke De Weerdt^7*, Inger S. Nijhof, MD, PhD^7*, Jurgen Wegman^1*, Nina Smit^1*, Christie P.M. Verkleij, MD^1,2*, Tuna Mutis, MD PhD^1,2*, Marjolein van der Klift, MD, PhD^8*, Laurens Franssen, MD PhD^9*, Kaz Groen, MD^1,2*, Ellen van der Spek, MD PhD^10*, Wilfried Roeloffzen^3*, Sonja Zweegman, MD, PhD^1,2 and Niels W.C.J. van de Donk, MD, PhD^1,2*

¹Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
²Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands
³Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
⁴Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
⁵Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
⁶Department of Internal Medicine, Northwest Clinics, Alkmaar, Netherlands
⁷Department of Hematology, St Antonius Hospital, Nieuwegein, Netherlands
⁸Department of Internal Medicine, Amphia Hospital, Breda, Netherlands
⁹Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands
¹⁰Department of Internal Medicine, Rijnstate hospital, Arnhem, Netherlands

Bo Qin, PhD^1*, Alexander B Jackman^1*, Yao-Cheng Li, PhD^1*, Jianying Wang^1*, Huang Qiu, PhD^1*, Nathan Onpaeng^1*, Steven Wilkens, PhD^1*, Virginia Grant^1*, Robyn L Stanfield, PhD^2*, Ian Wilson, PhD^2*, Imani Rogers^1*, Richard Labaudiniere, PhD^1*, Jeffery W Kelly, PhD^3*, H Michael Petrassi, PhD^1* and Xin Jiang, PhD^1*

¹Protego Biopharma, San Diego, CA
²Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA
³Department of Chemistry, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA

Adam D. Cohen, MD¹, Sandra Susanibar-Adaniya, MD², Oksana De Mesa, BSN, RN^2*, Alfred L. Garfall, MD², Dan T. Vogl, MD, MS², Adam Waxman, MD^2*, Shivani Kapur, MD², E Paul Wileyto^3*, Anjana Nair^2*, Zainul S. Hasanali, MD, PhD⁴, Lauren Karpf^5* and Edward A. Stadtmauer, MD²

¹Abramson Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
²Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
³Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadephia, PA
⁴Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
⁵Office of Clinical Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Laura Rosiñol Dachs, MD, PhD^1*, Albert Oriol, MD, PhD^2*, María-Jesús Blanchard, MD, PhD^3*, Javier de la Rubia^4*, Rafael Ríos, MD, PhD^5*, Joan Bargay^6*, Miguel Teodoro Hernández Garcia, MD, PhD^7*, Valentín Cabanas Perianes^8*, Ana López de la Guía^9*, Estrella Carrillo-Cruz, MD^10*, Anna Sureda Balari, MD, PhD¹¹, Joaquin Martínez-López^12*, Jose Maria Arguiñano, MD^13*, Esther González García, MD, PhD^14*, Luis Felipe Casado^15*, Josep Maria Marti Tutusaus^16*, Cristina Encinas^17*, Felipe De Arriba, MD, PhD^18*, Luis Palomera, MD, PhD^19*, Antonia Sampol Mayol, MD^20*, Yolanda González-Montes, MD, PhD^21*, Jordi López-Pardo^22*, Maialen Sirvent, PhD^23*, Maria Belen Inigo Rodriguez^24*, Bruno Paiva, PhD^25*, Noemi Puig, PhD²⁶, Maria Teresa Cedena Romero, MD, PhD^27*, Norma C. Gutierrez^28*, Javier De la Cruz, MD^29*, Maria-Victoria Mateos, MD, PhD³⁰, Jesús F. San-Miguel, MD, PhD³¹, Juan-Jose Lahuerta Palacios, MD, PhD^32* and Joan Bladé, MD, PhD^33*

¹Hematology, IDIBAPS, Hospital Clinic, Barcelona, ESP
²Hematology, Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
³Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁴Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
⁵Hospital Universitario Virgen De Las Nieves, Granada, ESP
⁶Hematology Department, Hospital Universitario Son Llàtzer. IdIsBa., Palma de Mallorca, Spain
⁷Hospital Universitario de Canarias, La Laguna, ESP
⁸Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
⁹Hospital Universitario La Paz, Madrid, Spain
¹⁰Complejo Hospitalario Regional Virgen del Rocío, Sevilla, Spain
¹¹Hematology Department, Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain
¹²Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, Madrid, Spain
¹³Complejo Hospitalario de Navarra, IdiSNA, Pamplona, Spain
¹⁴Hospital de Cabueñes, Gijón, Spain
¹⁵Hematology, Hospital General Universitario de Toledo, Toledo, Spain
¹⁶Hospital Universitari Mútua de Terrassa, Terrassa, Spain
¹⁷Hospital General Universitario Gregorio MarañóN, Madrid, Spain
¹⁸Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
¹⁹Hospital Clinico Universitario Lozano Blesa, Instituto Investigacion Sanitaria Aragon, Zaragoza, Spain
²⁰Hematology Department., Hospital Universitario Son Espases, IdISBa., Palma, Spain
²¹Hematology, Institut d'Oncologia Dr. Josep Trueta, Girona, Spain
²²Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
²³Hospital de Donostia, San Sebastián, Spain
²⁴HOSPITAL CLINICO SAN CARLOS, MADRID, Spain
²⁵Department of Hematology, Centre for Applied Medical Research, Cancer Center Clinica Universidad de Navarra, University of Navarra, IdiSNA, CIBERONC, Pamplona, Spain
²⁶Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
²⁷Instituto de Investigación IMAS12, Madrid, Spain
²⁸Hospital Universitario De Salamanca, IBSAL, Salamanca, Spain
²⁹Hospital Universitario 12 De Octubre, Instituto De Investigación Sanitaria,, Madrid, Spain
³⁰University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Salamanca, Spain
³¹Clínica Universitaria de Navarra, Pamplona, Spain
³²Hematology, Hospital Universitario 12 de Octubre, Imas12, CIBERONC, Madrid, Spain
³³Hospital Clinic, IDIBAPS, Barcelona, Spain

Graham Jackson, MD^1*, Charlotte Pawlyn, PhD^2,3, Faith E Davies, MD⁴, Martin F Kaiser, MD^2,3, Ruth M de Tute, MSc, PhD, FRCPath^5*, Heather McIntyre^6*, Jeanine Richards^6*, Sharon Jackson^6*, Elizabeth Hodson^6*, Anna Hockaday^6*, Catherine Olivier^6*, John R Jones^7,8,9*, Matthew W. Jenner^10*, Gordon Cook, PhD, DSc^6*, Walter Martin Gregory, PhD^6*, Mark Drayson^11*, Roger G Owen, MD, MRCP, FRCPath^5*, David A. Cairns, PhD^12* and Gareth Morgan, M.D., Ph.D.^4*

¹University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
²The Institute of Cancer Research, London, United Kingdom
³The Royal Marsden NHS Foundation Trust, London, United Kingdom
⁴Perlmutter Cancer Center, Multiple Myeloma Research Program, NYU Langone Health, New York, NY
⁵HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁶Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁷Kings College Hospital, London, United Kingdom
⁸Brighton and Sussex Medical School, Brighton, United Kingdom
⁹East Sussex NHS Trust, Eastbourne, United Kingdom
¹⁰University Hospital Southampton, Southampton, United Kingdom
¹¹University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom
¹²Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

Donna E Reece, MD¹, Giovanni Piza Rodriguez, MD^2*, Mariela A Pantoja, PhD, MSc^3*, Eshetu G Atenafu, MSc, PStat^4*, Darrell White, MD, MSc⁵, Irwindeep Sandhu, MD⁶, Julie Stakiw, MD⁷, Michael Sebag, MD, PhD⁸, Terrance Comeau, MD⁹, Kevin Song, MD¹⁰, Jean Roy, MD¹¹, Martha L Louzada, MD, MSc¹², Arleigh McCurdy, MD¹³, Vishal Kukreti, MD, MSc¹⁴, Suzanne Trudel, MD^15*, Anca Prica, MD², Rodger E Tiedemann, MBChB, PhD¹⁶ and Christine I Chen, MHPE, MD¹⁷

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre- University Health Network, Toronto, ON, Canada
²Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
³Princess Margaret Cancer Centre, Toronto, ON, CAN
⁴Princess Margaret Cancer Centre / University Health Network, Toronto, ON, Canada
⁵Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
⁶Cross Cancer Institute, Edmonton, AB, Canada
⁷Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, SK, Canada
⁸McGill University, Montréal, QC, Canada
⁹Saint John Regional Hospital, Saint John, NB, Canada
¹⁰BC Cancer Agency, Vancouver General Hospital, Vancouver, BC, Canada
¹¹Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
¹²London Health Sciences Centre, London, ON, Canada
¹³The Ottawa Hospital, Ottawa, ON, Canada
¹⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁵Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, Canada
¹⁶Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁷Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

Gang An^1*, Zhongxia Huang^2*, Aibin Liang^3*, Baijun Fang^4*, Hongmei Jing, MD⁵ and Lu-Gui Qiu, MD¹

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology&Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
²Multiple Myeloma Medical Center of Beijing, Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
³Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China
⁴Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
⁵Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China

Terri L. Parker, MD¹, Adam Rosenthal, MS^2*, Vaishali Sanchorawala³, Heather J. Landau, MD⁴, Erica L. Campagnaro, MD^5*, Prashant Kapoor, MD⁶, Natalia Neparidze, MD¹, Saulius Girnius, MD⁷, Patrick Hagen, MD, MPH^8*, Emma C. Scott, MD^9*, Antje Hoering, PhD¹⁰, Brian G.M. Durie¹¹ and Robert Z. Orlowski, MD, PhD¹²

¹Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
²SWOG Statistical and Data Management Center, Seattle, WA
³Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
⁴Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
⁶Mayo Clinic, Rochester, MN
⁷Trihealth Cancer Institute, Cincinnati, OH
⁸Division of Hematology and Oncology, Loyola University Health System, Maywood, IL
⁹Oregon Health and Science University, Portland, OR
¹⁰Cancer Research And Biostatistics, Seattle, WA
¹¹Cedars-Sinai Medical Center, Los Angeles, CA
¹²Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

J Christine Ye, MD, MSc¹, Philip Boonstra, PhD^2*, Erica L. Campagnaro, MD^3*, Matthew Pianko⁴, Andrew Kin, MD⁵, Larry D Anderson Jr., MD, PhD⁶, Brea Lipe, MD⁷, Moshe Talpaz, MD⁸ and Jeffrey A. Zonder, MD ⁹

¹Department of Lymphoma & Myeloma, UT MD Anderson Cancer Center, Houston, TX
²University of Michigan, Ann Arbor, MI
³Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
⁴Rogel Cancer Center, University of Michigan, Ann Arbor, MI
⁵Karmanos Cancer Institute/Wayne State University, Detroit, MI
⁶Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁷University of Rochester Medical Center, Rochester, NY
⁸University of Michigan Cancer Center, Ann Arbor, MI
⁹Karmanos Cancer Institute, Detroit, MI

Evangelos Terpos, MD, PhD¹, Maria Gavriatopoulou^1*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^1*, Panagiotis Malandrakis, MD^1*, Despina Fotiou, MD^1*, Magdalini Migkou, MD^1*, Foteini Theodorakakou, MD^1*, Vasiliki Spiliopoulou, MD^1*, Rodanthi Syrigou, MD^1*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Giorgos Psarros, MSc^2*, Efstathios Kastritis, MD^1* and Meletios Dimopoulos, MD¹

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Health Data Specialists, Dublin, Ireland

Robert Z. Orlowski, MD, PhD¹, Shambavi Richard, MD², Jonathan L. Kaufman, MD³, Sebastian Grosicki, MD, PhD^4*, Istvan Takacs^5*, Andras Strassz, MD, MBA⁶, Andreas Martin Pahl, PhD⁷, Michael Kulke^8*, Thorsten Michael, MBA^6,9*, Anette Last^10*, Hajnalka Szaboki^6*, Frank Richard, MD, MBA^6*, Oliver Schönborn-Kellenberger, MSc^11* and Marc S. Raab^12,13*

¹Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
³Winship Cancer Institute of Emory University, Atlanta, GA
⁴Medical University of Silesia, Katowice, Poland
⁵Ist Department of Medicine, Semmelweis University, Budapest, Hungary
⁶Heidelberg Pharma AG, Ladenburg, Germany
⁷Heidelberg Pharma, Ladenburg, Germany
⁸Heidelberg Pharma Research Gmbh, Ladenburg, Germany
⁹Heidelberg Pharma AG, Frankfurt am Main, HE, Germany
¹⁰Gregor-Mendel-Straße 22, Heidelberg Pharma AG, Ladenbuerg, Germany
¹¹Cogitars GmbH, Heidelberg, Germany
¹²Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
¹³Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Beatrice Razzo, MD^1,2, Sarah Girgis^1*, Leonard Finnaca^1*, Samantha Le^1*, Sara Whittington^1*, George Mellgard, MD³, Connor B Grady, MPH^4*, Zachary Wolfe, MD⁵, Adam F. Binder, MD², Rajshekhar Chakraborty, MD³, Christopher Strouse, MD⁶, Hira Shaikh, MD^6*, Shivani Kapur, MD¹, Sandra Susanibar-Adaniya, MD¹, Adam Waxman, MD^1*, Dan T. Vogl, MD, MS¹, Adam D. Cohen, MD⁷, Edward A. Stadtmauer, MD¹, Wei-Ting Hwang^8* and Alfred L. Garfall, MD¹

¹Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Department of Medical Oncology, Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center, Philadelphia, PA
³Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
⁴Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, MA
⁵Lehigh Valley Health Network, Allentown, PA
⁶Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa City, IA
⁷Abramson Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
⁸Department of Biostatistics, Epidemiology, and Informatics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

Yan Xu, MD^1*, Zhen Cai^2*, Zhongjun Xia, MD^3*, Chen Yang^4*, Jia Chen^4*, Zewen Zhu^4*, Xiaojuan Jing^4*, Ji Tian^4*, Nating Zhang^4*, Ailing Cui^4*, Jianxing Tang^4*, Haolin Sun^4* and Lugui Qiu⁵

¹Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
²Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
³Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁴Shanghai Xianxiang Medical Technology Co., Ltd., Shanghai, China
⁵State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Sikander Ailawadhi¹, Antje Hoering, PhD², J Christine Ye, MD, MSc³, Brea Lipe, MD⁴, Thomas R. Chauncey, MD, PhD^5,6*, Krisstina Gowin, DO⁷, David Calverley, MD⁸, Sarah A. Holstein, MD, PhD⁹, Erica L. Campagnaro, MD^10*, Adam Rosenthal, MS^11*, Jack Aiello^12*, Saad Z. Usmani, MD¹³, Vincent Rajkumar, MD^14* and Robert Z. Orlowski, MD, PhD¹⁵

¹Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
²Cancer Research And Biostatistics, Seattle, WA
³Department of Lymphoma & Myeloma, UT MD Anderson Cancer Center, Houston, TX
⁴University of Rochester Medical Center, Rochester, NY
⁵Seattle VA Medical Center (111 Onc.), Seattle, WA
⁶Division of Hematology & Oncology, University of Washington, Seattle, WA
⁷University of Arizona Cancer Center, UA College of Medicine, Tucson, AZ
⁸OHSU, Portland, OR
⁹Nebraska Medical Center, Omaha, NE
¹⁰Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
¹¹SWOG Statistical and Data Management Center, Seattle, WA
¹²In memoriam, Patient author, Southwest Oncology Group, San Jose, CA
¹³Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Division of Hematology, Mayo Clinic, Rochester, MN
¹⁵Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX